Inhibition of Herpes Simplex Virus Reactivation by Dipyridamole
AUTOR(ES)
Tenser, Richard B.
FONTE
American Society for Microbiology
RESUMO
Herpes simplex virus (HSV) reactivation from latency was investigated. Reactivation of thymidine kinase-negative HSV, which is defective for reactivation, was greatly enhanced by thymidine (TdR). The reactivation-enhancing effect of TdR was blocked by dipyridamole (DPM), a known nucleoside transport inhibitor. DPM also inhibited wild-type HSV reactivation, suggesting potential antiviral use.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90893Documentos Relacionados
- Mechanisms of herpes simplex virus type 1 reactivation.
- Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
- Inhibition of herpes simplex virus replication by methyl daunosamine.
- Reversible Inhibition of Herpes Simplex Virus Replication by Hydroxyurea
- Inhibition of Herpes Simplex Virus Replication by Phosphonoacetic Acid